Harvard spinout Emulate will use the cash to further develop its organ-on-a-chip technology, having now raised nearly $225m in total.

Dell, Hewlett Packard, Relx and Alphabet helped boost the database technology provider’s total funding to $264m.

SR One Capital Management has led the RNA targeting drug developer’s latest round, participating alongside investors including Lilly Asia Ventures.

The Aviva and Foxconn-backed respiratory system developer beat the target for its series D round to bring its total funding to over $150m.

Cigna has returned to invest $29.5m in electric vehicle charging technology developer Tritium ahead of its $1.2bn reverse merger later this year.

Scor joined returning investors Investec and Passion Capital to back the expat-focused auto insurance platform’s series B round, valuing it at $1.25bn.

LabCorp and Cedars-Sinai-backed Emulate will use the cash to further develop its organ-on-a-chip technology and has now raised nearly $225m in total.

The workforce training platform developer secured the cash in a series B2 round featuring HV Capital, taking its overall funding to over $130m.

Country Garden and Poly Group-backed Real Estate Industry Chain Empowerment Fund led a series B round for the vacuum cleaner producer that included Xiaomi.

SoftBank-backed cancer immunotherapy developer ICT has collected series C funding from CDH Investments’ CDH VGC unit.